Robust Multiepitope Vaccine from Glycoproteins Against Human Metapneumovirus Genotypes A2a, A2b, and A2c by Utilizing Immunoinformatics and Reverse Vaccinology Approaches

Abstract excerpt

Human metapneumovirus (HMPV) is a prominent respiratory pathogen causing significant morbidity and mortality worldwide, mostly in young teenagers, the old, and immunocompromised individuals. Despite its clinical impact, no licensed vaccine is currently available, highlighting the urgent need for effective prophylactic strategies. This research aimed to design a multiepitope vaccine (MEV) targeting conserved and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Pneumonia and Respiratory Infections
• Share to Respiratory viral infections research
• Share to vaccines and immunoinformatics approaches